Ken MacLeod
Directeur/Membre du Conseil chez SEQUANA MEDICAL N.V.
Profil
Ken MacLeod is currently a Director at JenaValve Technology, Inc., a Director at Oxular Ltd., and a Non-Executive Director at Sequana Medical NV.
He has formerly held positions as a Director at On-X Life Technologies, Inc., Pharming Group NV, and Cryogenics, Inc. Dr. MacLeod received an undergraduate degree from The University of Manchester and a doctorate degree from The University of York.
Postes actifs de Ken MacLeod
| Sociétés | Poste | Début |
|---|---|---|
| SEQUANA MEDICAL N.V. | Directeur/Membre du Conseil | 01/06/2023 |
JenaValve Technology, Inc.
 JenaValve Technology, Inc. Medical SpecialtiesHealth Technology JenaValve Technology, Inc. designs, develops, manufactures, and markets transcatheter aortic valve replacement systems. The company was founded on March 27, 2006 and is headquartered in Wilmington, DE. | Directeur/Membre du Conseil | 05/04/2023 |
Oxular Ltd.
 Oxular Ltd. BiotechnologyHealth Technology Oxular Ltd. engages in research and experimental development on biotechnology. The firm develops retinal treatments to access specific small spaces in the eye and to provide drug distribution to tissues involved in retinal diseases. The company was founded by Tom Cavanagh and Ronald K. Yamamoto in 2014 and is headquartered in Oxford, the United Kingdom. | Directeur/Membre du Conseil | - |
Anciens postes connus de Ken MacLeod
| Sociétés | Poste | Fin |
|---|---|---|
On-X Life Technologies, Inc.
 On-X Life Technologies, Inc. Medical SpecialtiesHealth Technology On-X Life Technologies, Inc. develops, manufactures, and markets heart valve replacements. The firm offers prosthetic heart valves, pyrolytic carbon coating, and technical services in carbon based technology including medical design and product development. The company was founded by Jack C. Bokros in April 1994 and is headquartered in Austin, TX. | Directeur/Membre du Conseil | - |
Cryogenics, Inc.
 Cryogenics, Inc. Oilfield Services/EquipmentIndustrial Services Cryogenics, Inc. manufactures equipment for the petrochemical industry. | Directeur/Membre du Conseil | - |
| PHARMING GROUP N.V. | Directeur/Membre du Conseil | - |
Formation de Ken MacLeod
| The University of Manchester | Undergraduate Degree |
| The University of York | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| PHARMING GROUP N.V. | Health Technology |
| SEQUANA MEDICAL N.V. | Health Technology |
| Entreprise privées | 4 |
|---|---|
On-X Life Technologies, Inc.
On-X Life Technologies, Inc. Medical SpecialtiesHealth Technology On-X Life Technologies, Inc. develops, manufactures, and markets heart valve replacements. The firm offers prosthetic heart valves, pyrolytic carbon coating, and technical services in carbon based technology including medical design and product development. The company was founded by Jack C. Bokros in April 1994 and is headquartered in Austin, TX. | Health Technology |
Cryogenics, Inc.
Cryogenics, Inc. Oilfield Services/EquipmentIndustrial Services Cryogenics, Inc. manufactures equipment for the petrochemical industry. | Industrial Services |
JenaValve Technology, Inc.
JenaValve Technology, Inc. Medical SpecialtiesHealth Technology JenaValve Technology, Inc. designs, develops, manufactures, and markets transcatheter aortic valve replacement systems. The company was founded on March 27, 2006 and is headquartered in Wilmington, DE. | Health Technology |
Oxular Ltd.
Oxular Ltd. BiotechnologyHealth Technology Oxular Ltd. engages in research and experimental development on biotechnology. The firm develops retinal treatments to access specific small spaces in the eye and to provide drug distribution to tissues involved in retinal diseases. The company was founded by Tom Cavanagh and Ronald K. Yamamoto in 2014 and is headquartered in Oxford, the United Kingdom. | Health Technology |
